BREA, Calif., Aug. 7, 2019 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today that its small, but mighty DxH 520 hematology analyzer received the Scientists' ...

Available on the DxH 690T, the Early Sepsis Indicator is the only FDA-cleared hematologic biomarker specifically for aiding in the early diagnosis of sepsis BREA, Calif., May 18, 2020 /PRNewswire/ -- ...

The technology is superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making SANTA CLARA, California, Sept. 15, 2020 /PRNewswire/ -- ...

The FDA is warning hospitals, laboratories and clinicians about a Class 1 recall of three hematology analyzers manufactured by Beckman Coulter after several reports of inaccuracies related to blood ...

System helps laboratories deliver fast, accurate results through near native-state cellular characterization, precise flagging and a 93% first-pass throughput 1 "The DxH 900 hematology analyzer is an ...

BREA, California, Jan. 7, 2020 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today that South West London Pathology (SWLP) has implemented DxH 900 haematology ...

Beckman Coulter Diagnostics has released the DxH 500 haematology system with CE Mark, an open-vial instrument offering a throughput of up to 60 samples per hour1. The DxH 500 haematology system is the ...

The technology is superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making The DxH 690T's automated capabilites are a significant ...

"The DxH 690T leverages flagship products in the Beckman Coulter Diagnostics' portfolio, specifically the enhanced Coulter Principle, VCS technology and DataFusion, to provide precise cellular ...